medigraphic.com
ISSN 1561-3011 (Electronic)

2021, Number 3

<< Back Next >>

Rev Cubana Invest Bioméd 2021; 40 (3)

Chronic kidney disease and prognosis of COVID-19 patients

Cobiellas CLI, Bonet CL, Plasencia UTM, Almaguer MLE

Language: Spanish
References: 36
Page: 1-19
PDF size: 506.83 Kb.


ABSTRACT

Introduction: COVID-19 has triggered a global public health emergency, for it has infected and caused the death of millions of people, thus unleashing an unprecedented humanitarian crisis. Deaths due to COVID-19 have also been associated to the presence of several chronic diseases.
Objective: Evaluate the association between chronic kidney disease and the worst prognosis of COVID-19 patients.
Methods: A search was conducted in the databases PubMed, Scopus, EBSCO Host, Clinical Key, Hinari and Cochrane for observational papers published before 30 April 2020 which contained relevant information about the outcome of patients with COVID-19 and chronic kidney disease.
Results: A total 13 papers were included which summarize information about 8 207 patients, 405 (4.9%) of them with chronic kidney disease. Comorbidity was associated to a worse prognosis of COVID-19 patients, with OR = 1.99 [CI 95%: 1.13-3.52; Z = 2.37; p = 0.02] and heterogeneity I2 = 47%, (2 = 22.47 (p = 0.03). After deleting the studies with a greater contribution to heterogeneity, an analysis was conducted of the information about 5 924 patients, finding a greater association between chronic kidney disease and worst prognosis, with OR = 3.02 [CI 95%: 1.79-5.10; Z = 4.15; p < 0.0001] and heterogeneity I2 = 0%, (2 = 3.78 (p = 0.88). This implies that patients with chronic kidney disease affected by COVID-19 have three times as many chances of having a worse prognosis than the general population.
Conclusions: Chronic kidney disease worsens the prognosis of COVID-19 patients.


REFERENCES

  1. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. J Med Virol. 2020 [acceso: 24/04/2020];92:1902-14. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25884

  2. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. 2020;97(6):1083-8. DOI: 10.1016/j.kint.2020.04.002

  3. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):1-8. DOI: 10.1001/jamacardio.2020.1017

  4. Organización Mundial de la Salud. Coronavirus disease (COVID-19). Situation Report - 158. Ginebra; 2020 June [acceso: 24/04/2020]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200626-covid-19-sitrep-158.pdf?sfvrsn=1d1aae8a_2

  5. Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020;47(5):1275-80. DOI: 10.1007/s00259-020-04735-9

  6. Malha L, Mueller FB, Pecker MS, Mann SJ, August P, Feig PU. COVID-19 and the Renin-Angiotensin System. Kidney Int Rep. 2020;5(5):563-5. DOI: 10.1016/j.ekir.2020.03.024

  7. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020 Mar [acceso: 24/04/2020];NEJMsr2005760. DOI: doi.org/10.1056/NEJMsr2005760

  8. Rombolà G, Hedemperger M, Pedrini L, Farina M, Aucella F, Messa P, et al. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J Nephrol. 2020;1-4. DOI: 10.1007/s40620-020-00727

  9. Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J. 2020;55(5):2000547. DOI: 10.1183/13993003.00547-2020

  10. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020;8(1):e35. PMCID: PMC7096724

  11. Wang H. Maintenance Hemodialysis and Coronavirus Disease 2019 (COVID-19): Saving Lives with Caution, Care, and Courage. Kidney Med. 2020;2(3):365-6. DOI: 10.1016/j.xkme.2020.03.003

  12. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639-45. DOI: 10.1016/j.inf.2020.03.019

  13. Review Manager. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration; 2014 [acceso: 24/04/2020]. Disponible en: https://tech.cochrane.org/revman/

  14. da Silva FC, Arancibia BAV, Iop R da R, Filho PJBG, da Silva R. Escalas y listas de evaluación de la calidad de estudios científicos. Rev Cuba Inf Cienc Salud. 2013 [acceso: 02/05/2020]; 24(3). Disponible en: http://www.acimed.sld.cu/index.php/acimed/article/view/438

  15. Cao J, Tu W-J, Cheng W, Yu L, Liu Y-K, Hu X, et al. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Jul [acceso: 26/04/2020]; 71(15):748-55. Disponible en: https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa243/5814897

  16. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 [acceso: 24/04/2020]; 368:m1091. Disponible en: https://www.bmj.com/content/368/bmj.m1091

  17. Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study. J Clin Virol. 2020;127:104378. DOI: 10.1016/j.jcv.2020.104378

  18. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 [acceso: 04/05/2020]; 395(10229):1054-62. Disponible en: http://www.sciencedirect.com/science/article/pii/S0140673620305663

  19. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26(6):767-72. DOI: 10.1016/j.cmi.2020.04.012

  20. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. DOI: 10.1056/NEJMoa2002032

  21. Wang L, Li X, Chen H, Yan S, Li D, Li Y, et al. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol. 2020 [acceso: 24/04/2020];51(5):343-8. Disponible en: https://www.karger.com/Article/FullText/507471

  22. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. Infectious Diseases. 2020. [acceso: 26/04/2020]. Disponible en: https://www.medrxiv.org/content/10.1101/2020.02.22.20026500v1

  23. Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020 [acceso: 24/04/2020]; 75(7):1730-41. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14238

  24. Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of Hospitalized Adults with COVID-19 in an Integrated Health Care System in California. JAMA. 2020 [acceso: 24/04/2020]; 323(21):2195-8. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2765303

  25. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 [acceso: 26/04/2020]; 323(11):1061-9. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2761044

  26. Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. DOI: 10.1186/s40249-020-00646-x

  27. Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. DOI: 10.3389/fpubh.2020.00152

  28. Rabb H. Kidney diseases in the time of COVID-19: major challenges to patient care. J Clin Invest. 2020;130(6):2749-51. DOI: 10.1172/JCI138871

  29. Lambers Heerspink HJ, de Borst MH, Bakker SJ, Navis GJ. Improving the efficacy of RAAS blockade in patients with chronic kidney disease. Nat Rev Nephrol. 2013;9(2):112-21. PMID: 23247573

  30. Kim CS, Kim IJ, Bae EH, Ma SK, Lee JU, Kim SW. Angiotensin-(1-7) attenuates kidney injury due to obstructive nephropathy in rats. PloS One. 2015;10(11):e0142664. DOI: 10.1371/journal.pone.0142664

  31. Choi HS, Kim IJ, Kim CS, Ma SK, Scholey JW, Kim SW, et al. Angiotensin-[1-7] attenuates kidney injury in experimental Alport syndrome. Sci Rep. 2020;10(1):1-11. DOI: 10.1038/s415998-020-61250-5

  32. Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020;81(5):537-40. DOI: 10.1002/ddr.21656

  33. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-74. DOI: 10.1007/s11427-020-1643-8

  34. Malha L, Mueller FB, Pecker MS, Mann SJ, August P, Feig PU. COVID-19 and the Renin-Angiotensin System. Kidney Int Rep. 2020;5(5):563-5. DOI: 10.1016/j.ekir.2020.03.024

  35. Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu M. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension. 2014;64(6):1368-75. DOI: 10.1161/HYPERTENSIONAHA.114.03743

  36. Khouchlaa A, Bouyahya A. COVID-19 nephropathy: probable mechanisms of kidney failure. J Nephropathol. 2020;9(4):e35. DOI: 10.34172/jnp.20.35




2020     |     www.medigraphic.com